Ibere Pharmaceuticals
IBER-UN
New York Stock Exchange10.16
USD
- -
- -
CIK
0001835205
Return %
Stock
S&P500
1Y
2.94
26.53
3Y
0.59
76.60
5Y
0.59
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Osagie O. Imasogie
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 2005 Market Street Philadelphia PA United States of America 19103
- CIK
- 0001835205
- Website
- iberepharma.com
- Similar Companies
- Business
- Ibere Pharmaceuticals Ibere Pharmaceuticals (IBER-UN) is a blank check company with no significant current operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities, particularly targeting opportunities in the pharmaceutical sector. Incorporated in 2020 as a Cayman Islands exempted company and headquartered in Philadelphia, Pennsylvania, the company completed its initial public offering of $138,000,000 in 2021 to fund its pursuit of a business combination.